Abstract

Loss of imprinting (LOI), an epigenetic alteration affecting the insulin-like growth factor II gene ( IGF2 ), is found in normal colonic mucosa of about 30% of colorectal cancer (CRC) patients, but it is found in only 10% of healthy individuals. In a pilot study to investigate the utility of LOI as a marker of CRC risk, we evaluated 172 patients at a colonoscopy clinic. The adjusted odds ratio for LOI in lymphocytes was 5.15 for patients with a positive family history [95% confidence interval (95% CI), 1.70 to 16.96; probability P = 0.002], 3.46 for patients with adenomas (95% CI, 1.14 to 11.37; P = 0.026), and 21.7 for patients with CRC (95% CI, 3.48 to 153.6; P = 0.0005). LOI can be assayed with a DNA-based blood test, and it may be a valuable predictive marker of an individual's risk for CRC.

Keywords

Colorectal cancerOdds ratioInternal medicineMedicineConfidence intervalColonoscopyImprinting (psychology)OncologyFamily historyGenomic imprintingGastroenterologyCancerGeneDNA methylationBiologyGeneticsGene expression

Affiliated Institutions

Related Publications

Publication Info

Year
2003
Type
article
Volume
299
Issue
5613
Pages
1753-1755
Citations
729
Access
Closed

External Links

View on DOI.org

Social Impact

Altmetric
PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

729
OpenAlex

Cite This

Hengmi Cui, Marcia Cruz‐Correa, Francis M. Giardiello et al. (2003). Loss of <i>IGF2</i> Imprinting: A Potential Marker of Colorectal Cancer Risk. Science , 299 (5613) , 1753-1755. https://doi.org/10.1126/science.1080902

Identifiers

DOI
10.1126/science.1080902